These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6089155)

  • 1. Studies on the neurochemical basis of action of antidepressant drugs and electroconvulsive treatment.
    Vetulani J
    Pol J Pharmacol Pharm; 1984; 36(2-3):101-15. PubMed ID: 6089155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex action of antidepressant treatment on central adrenergic system: possible relevance to clinical effects.
    Vetulani J
    Pharmacopsychiatry; 1984 Jan; 17(1):16-21. PubMed ID: 6324248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments.
    Vetulani J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Pilc A
    Pol J Pharmacol Pharm; 1984; 36(2-3):231-48. PubMed ID: 6089158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission.
    Mongeau R; de Montigny C; Blier P
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1152-9. PubMed ID: 7912278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central alpha-adrenoceptors and the mechanisms of action of antidepressant drugs.
    Svensson TH
    Adv Biochem Psychopharmacol; 1984; 39():241-8. PubMed ID: 6087627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 2-adrenoceptors in depression.
    Katona CL; Theodorou AE; Horton RW
    Psychiatr Dev; 1987; 5(2):129-49. PubMed ID: 2819861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology of central noradrenergic receptors (author's transl)].
    Besson MJ; Reisine TD
    Encephale; 1982; 8(2):177-92. PubMed ID: 6286276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of antidepressant drugs and electroconvulsive shock on brain alpha 1-adrenoceptors following destruction of noradrenergic or serotonergic nerve terminals.
    Nowak G; Przegaliński E
    Pol J Pharmacol Pharm; 1988; 40(4):393-400. PubMed ID: 2851781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies.
    de Montigny C; Blier P
    Adv Biochem Psychopharmacol; 1984; 39():223-39. PubMed ID: 6087626
    [No Abstract]   [Full Text] [Related]  

  • 12. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiological correlates of the antidepressant action of electroconvulsive therapy.
    Mann JJ
    J ECT; 1998 Sep; 14(3):172-80. PubMed ID: 9773356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies on central noradrenergic synaptic mechanisms after acute and chronic antidepressant drug treatment: biochemical and behavioral comparison.
    Racagni G; Mocchetti I; Renna G; Cuomo V
    J Pharmacol Exp Ther; 1982 Oct; 223(1):227-34. PubMed ID: 7120121
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic mechanisms of action of antidepressants.
    Frazer A; Conway P
    Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of antidepressant neuroleptics, chlorprothixene and levomepromazine, on the central noradrenergic system: comparison with other antidepressants.
    Antkiewicz-Michaluk L
    Pol J Pharmacol Pharm; 1985; 37(5):673-83. PubMed ID: 3008133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of alpha 2-adrenoceptors in the mechanism of action of antidepressant drugs.
    Pilc A
    Pol J Pharmacol Pharm; 1987; 39(6):691-713. PubMed ID: 2847126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central effects following repeated treatment with antidepressant drugs.
    Maj J
    Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.